There are dozens of investigational GLP-1 medicines in development. Novo Nordisk, the leader in the field, arguably has the ...

Novo Nordisk's Wegovy has received backing from the EU's medical regulator to expand the weight loss drug's use to reducing ...

Bagsværd, Denmark Monday, July 29, 2024, 13:00 Hrs [IST] ...

Novo Nordisk — the pharmaceutical giant behind popular weight-loss drugs Ozempic and Wegovy — spent a record $3.2 million on ...

Novo Nordisk , the maker of weight-loss drug Wegovy, has bought a site in Denmark's third largest city Odense and begun ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Novo Nordisk. Looking at options history for ...

Like Eli Lilly & Co.’s weight-loss drug Zepbound, VK2735 acts on two different gut hormones, GLP-1 and GIP. In a phase 2 ...

Wegovy presents an urgent challenge to the sustainability of Medicare and Medicaid, whose budgetary outlook under the status ...

Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight ...

After filing 13 lawsuits in 2023 claiming trademark infringement, deceptive trade practices, and false advertising related to ...

The Netherlands should not cover the cost of Novo Nordisk A/S’s Wegovy as it’s too expensive and there are “major ...

Health regulators in the U.K. on Tuesday approved Novo Nordisk’s weight loss injection semaglutide—the active ingredient in ...